Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 259

1.

Impact of diabetes on sarcopenia and mortality in patients undergoing hemodialysis.

Mori K, Nishide K, Okuno S, Shoji T, Emoto M, Tsuda A, Nakatani S, Imanishi Y, Ishimura E, Yamakawa T, Shoji S, Inaba M.

BMC Nephrol. 2019 Mar 28;20(1):105. doi: 10.1186/s12882-019-1271-8.

2.

Novel increasing dose regimen of tolvaptan for autosomal dominant polycystic kidney disease in patient with low tolerability.

Nakatani S, Ishimura E, Machiba Y, Nakatani A, Fujimoto K, Uedono H, Okute Y, Tsuda A, Mori K, Emoto M, Inaba M.

Nephrology (Carlton). 2018 Aug;23(8):798-799. doi: 10.1111/nep.13196. No abstract available.

PMID:
30920106
3.

Significance of urinary C-megalin excretion in vitamin D metabolism in pre-dialysis CKD patients.

Toi N, Inaba M, Ishimura E, Tsugawa N, Imanishi Y, Emoto M, Hirayama Y, Nakatani S, Saito A, Yamada S.

Sci Rep. 2019 Feb 18;9(1):2207. doi: 10.1038/s41598-019-38613-8.

4.

Effects of Long-Term Cinacalcet Administration on Parathyroid Gland in Hemodialysis Patients with Secondary Hyperparathyroidism.

Okuno S, Inaba M, Ishimura E, Nakatani S, Chou H, Shoji S, Yamakawa T.

Nephron. 2019;142(2):106-113. doi: 10.1159/000496808. Epub 2019 Feb 1.

PMID:
30712039
5.

Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial.

J-DAVID Investigators, Shoji T, Inaba M, Fukagawa M, Ando R, Emoto M, Fujii H, Fujimori A, Fukui M, Hase H, Hashimoto T, Hirakata H, Honda H, Hosoya T, Ikari Y, Inaguma D, Inoue T, Isaka Y, Iseki K, Ishimura E, Itami N, Ito C, Kakuta T, Kawai T, Kawanishi H, Kobayashi S, Kumagai J, Maekawa K, Masakane I, Minakuchi J, Mitsuiki K, Mizuguchi T, Morimoto S, Murohara T, Nakatani T, Negi S, Nishi S, Nishikawa M, Ogawa T, Ohta K, Ohtake T, Okamura M, Okuno S, Shigematsu T, Sugimoto T, Suzuki M, Tahara H, Takemoto Y, Tanaka K, Tominaga Y, Tsubakihara Y, Tsujimoto Y, Tsuruya K, Ueda S, Watanabe Y, Yamagata K, Yamakawa T, Yano S, Yokoyama K, Yorioka N, Yoshiyama M, Nishizawa Y.

JAMA. 2018 Dec 11;320(22):2325-2334. doi: 10.1001/jama.2018.17749.

6.

Non-mercaptalbumin, Oxidized Form of Serum Albumin, Significantly Associated with Renal Function and Anemia in Chronic Kidney Disease Patients.

Nakatani S, Yasukawa K, Ishimura E, Nakatani A, Toi N, Uedono H, Tsuda A, Yamada S, Ikeda H, Mori K, Emoto M, Yatomi Y, Inaba M.

Sci Rep. 2018 Nov 14;8(1):16796. doi: 10.1038/s41598-018-35177-x.

7.

Association of Albuminuria With Intraglomerular Hydrostatic Pressure and Insulin Resistance in Subjects With Impaired Fasting Glucose and/or Impaired Glucose Tolerance.

Tsuda A, Ishimura E, Uedono H, Ochi A, Nakatani S, Morioka T, Mori K, Uchida J, Emoto M, Nakatani T, Inaba M.

Diabetes Care. 2018 Nov;41(11):2414-2420. doi: 10.2337/dc18-0718. Epub 2018 Sep 13.

PMID:
30217931
8.

The Efficacy of Low-Density Lipoprotein Apheresis in a Patient with Drug-Resistant Minimal Change Nephrotic Syndrome: A Case Report and A Review of the Literature.

Nakatani S, Ishimura E, Okute Y, Nakatani A, Uedono H, Tsuda A, Naganuma T, Takemoto Y, Mori K, Emoto M, Inaba M.

Nephrology (Carlton). 2018 Jun;23(6):603-604. doi: 10.1111/nep.13120. Review. No abstract available.

PMID:
29890046
9.

Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.

Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Yoshio T, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.

Clin Exp Nephrol. 2018 Dec;22(6):1266-1280. doi: 10.1007/s10157-018-1579-x. Epub 2018 Apr 20.

PMID:
29679356
10.

Urinary Iron Excretion is Associated with Urinary Full-Length Megalin and Renal Oxidative Stress in Chronic Kidney Disease.

Nakatani S, Nakatani A, Ishimura E, Toi N, Tsuda A, Mori K, Emoto M, Hirayama Y, Saito A, Inaba M.

Kidney Blood Press Res. 2018;43(2):458-470. doi: 10.1159/000488470. Epub 2018 Mar 22.

11.

Xanthine oxidoreductase activity is associated with serum uric acid and glycemic control in hemodialysis patients.

Nakatani A, Nakatani S, Ishimura E, Murase T, Nakamura T, Sakura M, Tateishi Y, Tsuda A, Kurajoh M, Mori K, Emoto M, Inaba M.

Sci Rep. 2017 Nov 13;7(1):15416. doi: 10.1038/s41598-017-15419-0.

12.

Augmented O-GlcNAcylation of AMP-activated kinase promotes the proliferation of LoVo cells, a colon cancer cell line.

Ishimura E, Nakagawa T, Moriwaki K, Hirano S, Matsumori Y, Asahi M.

Cancer Sci. 2017 Dec;108(12):2373-2382. doi: 10.1111/cas.13412. Epub 2017 Oct 21.

13.

Focal accumulation of 67 gallium in the kidney in a patient with anti-glomerular basement membrane glomerulonephritis.

Ishimura E, Okute Y, Nakatani S, Ichii M, Tsuda A, Inaba M.

Nephrology (Carlton). 2017 Sep;22(9):728-729. doi: 10.1111/nep.12918. No abstract available.

PMID:
28792126
14.

The association of serum adiponectin with abdominal aortic calcification in Japanese male hemodialysis patients: a cross-sectional observational study.

Sakura T, Okuno S, Nishio E, Norimine K, Ishimura E, Yamakawa T, Shoji S, Inaba M.

Sci Rep. 2017 Jul 25;7(1):6434. doi: 10.1038/s41598-017-06850-4.

15.

U-shaped relationship between serum uric acid levels and intrarenal hemodynamic parameters in healthy subjects.

Uedono H, Tsuda A, Ishimura E, Nakatani S, Kurajoh M, Mori K, Uchida J, Emoto M, Nakatani T, Inaba M.

Am J Physiol Renal Physiol. 2017 Jun 1;312(6):F992-F997. doi: 10.1152/ajprenal.00645.2016. Epub 2017 Mar 1.

16.

High Coronary Heart Disease Risk in Hemodialysis Patients with Central Sleep Apnea: A Pilot Study.

Sakura M, Inaba M, Yoda K, Ichii M, Yamada S, Yamakawa T, Ishimura E, Okuno S, Shoji S.

Am J Nephrol. 2016;44(5):388-395. Epub 2016 Oct 22.

PMID:
27771703
17.

Erratum to: Evidence-based clinical practice guidelines for polycystic kidney disease 2014.

Horie S, Mochizuki T, Muto S, Hanaoka K, Fukushima Y, Narita I, Nutahara K, Tsuchiya K, Tsuruya K, Kamura K, Nishio S, Suwabe T, Ubara Y, Ishimura E, Nakanishi K, Furukawa K, Kimura K, Matsuo S.

Clin Exp Nephrol. 2016 Aug;20(4):510. doi: 10.1007/s10157-016-1285-5. No abstract available.

PMID:
27358079
18.

Silent Cerebral Microbleeds and Longitudinal Risk of Renal and Cardiovascular Events in Patients with CKD.

Shima H, Mori T, Ooi M, Sonoda M, Shoji T, Ishimura E, Okamura M, Ishizaka N, Inaba M.

Clin J Am Soc Nephrol. 2016 Sep 7;11(9):1557-65. doi: 10.2215/CJN.13481215. Epub 2016 Jun 27.

19.

Evidence-based clinical practice guidelines for polycystic kidney disease 2014.

Horie S, Mochizuki T, Muto S, Hanaoka K, Fukushima Y, Narita I, Nutahara K, Tsuchiya K, Tsuruya K, Kamura K, Nishio S, Suwabe T, Ubara Y, Ishimura E, Nakanishi K, Furukawa K, Kimura K, Matsuo S.

Clin Exp Nephrol. 2016 Aug;20(4):493-509. doi: 10.1007/s10157-015-1219-7. No abstract available. Erratum in: Clin Exp Nephrol. 2016 Aug;20(4):510.

20.

Association of Increased Serum Ferritin With Impaired Muscle Strength/Quality in Hemodialysis Patients.

Nakagawa C, Inaba M, Ishimura E, Yamakawa T, Shoji S, Okuno S.

J Ren Nutr. 2016 Jul;26(4):253-7. doi: 10.1053/j.jrn.2016.01.011. Epub 2016 Feb 23.

PMID:
26920091
21.

Comparison of the Estimated Glomerular Filtration Rate (eGFR) in Diabetic Patients, Non-Diabetic Patients and Living Kidney Donors.

Tsuda A, Ishimura E, Uedono H, Yasumoto M, Ichii M, Nakatani S, Mori K, Uchida J, Emoto M, Nakatani T, Inaba M.

Kidney Blood Press Res. 2016;41(1):40-7. doi: 10.1159/000368545. Epub 2016 Feb 3.

22.

[A Case of Type 2 Diabetes with Renal Failure and History of Preexisting Hyperglycemia Masked by Insulinoma].

Kawarabayashi R, Morioka T, Emoto M, Kakutani Y, Miyabe M, Yamazaki Y, Fukumoto S, Ishimura E, Amano R, Hirakawa K, Inaba M.

Nihon Naika Gakkai Zasshi. 2015 Oct;104(10):2185-92. Japanese. No abstract available.

PMID:
30160932
23.

Prevalence of Fabry disease in dialysis patients: Japan Fabry disease screening study (J-FAST).

Saito O, Kusano E, Akimoto T, Asano Y, Kitagawa T, Suzuki K, Ishige N, Akiba T, Saito A, Ishimura E, Hattori M, Hishida A, Guili C, Maruyama H, Kobayashi M, Ohashi T, Matsuda I, Eto Y.

Clin Exp Nephrol. 2016 Apr;20(2):284-93. doi: 10.1007/s10157-015-1146-7. Epub 2015 Jul 22.

PMID:
26197777
24.

Cerebral Microbleeds Predict Intracerebral Hemorrhage in Hemodialysis Patients.

Naganuma T, Takemoto Y, Shoji T, Ishimura E, Okamura M, Nakatani T.

Stroke. 2015 Aug;46(8):2107-12. doi: 10.1161/STROKEAHA.115.009324. Epub 2015 Jun 18.

PMID:
26089331
25.

Fibroblast Growth Factor-23 and Vitamin D Metabolism in Subjects with eGFR ≥60 ml/min/1.73 m².

Nakatani S, Nakatani A, Tsugawa N, Yamada S, Mori K, Imanishi Y, Ishimura E, Okano T, Inaba M.

Nephron. 2015;130(2):119-26. doi: 10.1159/000430870. Epub 2015 Jun 9.

PMID:
26068724
26.

Indoxyl sulfate suppresses hepatic fetuin-A expression via the aryl hydrocarbon receptor in HepG2 cells.

Ochi A, Mori K, Nakatani S, Emoto M, Morioka T, Motoyama K, Fukumoto S, Imanishi Y, Shoji T, Ishimura E, Inaba M.

Nephrol Dial Transplant. 2015 Oct;30(10):1683-92. doi: 10.1093/ndt/gfv250. Epub 2015 Jun 11.

PMID:
26068716
27.

Relationship between serum uric acid levels and intrarenal hemodynamic parameters.

Uedono H, Tsuda A, Ishimura E, Yasumoto M, Ichii M, Ochi A, Ohno Y, Nakatani S, Mori K, Uchida J, Nakatani T, Inaba M.

Kidney Blood Press Res. 2015;40(3):315-22. doi: 10.1159/000368507. Epub 2015 Jun 8.

28.

Significant association between glycemic status and increased estimated postglomerular resistance in nondiabetic subjects - study of inulin and para-aminohippuric acid clearance in humans.

Yasumoto M, Tsuda A, Ishimura E, Uedono H, Ohno Y, Ichii M, Ochi A, Nakatani S, Mori K, Uchida J, Emoto M, Nakatani T, Inaba M.

Physiol Rep. 2015 Mar;3(3). pii: e12321. doi: 10.14814/phy2.12321.

29.

Myeloid HIF-1 attenuates the progression of renal fibrosis in murine obstructive nephropathy.

Tateishi Y, Osada-Oka M, Tanaka M, Shiota M, Izumi Y, Ishimura E, Motoyama K, Inaba M, Miura K.

J Pharmacol Sci. 2015 Feb;127(2):181-9. doi: 10.1016/j.jphs.2014.12.011. Epub 2014 Dec 27.

30.

Effects of febuxostat on serum urate level in Japanese hyperuricemia patients.

Yamamoto T, Hidaka Y, Inaba M, Ishimura E, Ooyama H, Kakuda H, Moriwaki Y, Higami K, Ohtawara A, Hosoya T, Nishikawa H, Taniguchi A, Ueda T, Yamauchi T, Fujimori S, Mineo I, Yamanaka H.

Mod Rheumatol. 2015 Sep;25(5):779-83. doi: 10.3109/14397595.2015.1016257. Epub 2015 Jun 12. Erratum in: Mod Rheumatol. 2017 Jan;27(1):184.

PMID:
25671406
31.

Restoration of parathyroid function after change of phosphate binder from calcium carbonate to lanthanum carbonate in hemodialysis patients with suppressed serum parathyroid hormone.

Inaba M, Okuno S, Nagayama H, Yamada S, Ishimura E, Imanishi Y, Shoji S.

J Ren Nutr. 2015 Mar;25(2):242-6. doi: 10.1053/j.jrn.2014.10.013. Epub 2014 Dec 30. Review.

PMID:
25556148
32.

Injectable cell scaffold restores impaired cell-based therapeutic angiogenesis in diabetic mice with hindlimb ischemia.

Takeda K, Fukumoto S, Motoyama K, Morioka T, Mori K, Kageyama K, Sakai Y, Sato H, Suzuki M, Koyama H, Shoji T, Ishimura E, Emoto M, Furuzono T, Nakajima K, Inaba M.

Biochem Biophys Res Commun. 2014 Nov 7;454(1):119-24. doi: 10.1016/j.bbrc.2014.10.045. Epub 2014 Oct 18.

PMID:
25450367
33.

Serum β2-microglobulin correlates positively with left ventricular hypertrophy in long-term hemodialysis patients.

Masuda M, Ishimura E, Ochi A, Tsujimoto Y, Tahahra H, Okuno S, Tabata T, Nishizawa Y, Inaba M.

Nephron Clin Pract. 2014;128(1-2):101-6. doi: 10.1159/000365447. Epub 2014 Nov 4.

PMID:
25376242
34.

Significant association between bone-specific alkaline phosphatase and vascular calcification of the hand arteries in male hemodialysis patients.

Ishimura E, Okuno S, Okazaki H, Norimine K, Yamakawa K, Yamakawa T, Shoji S, Nishizawa Y, Inaba M.

Kidney Blood Press Res. 2014;39(4):299-307. doi: 10.1159/000355807. Epub 2014 Sep 16.

35.

Advantage of insulin glulisine over regular insulin in patients with type 2 diabetes and severe renal insufficiency.

Urata H, Mori K, Emoto M, Yamazaki Y, Motoyama K, Morioka T, Fukumoto S, Koyama H, Shoji T, Ishimura E, Inaba M.

J Ren Nutr. 2015 Mar;25(2):129-34. doi: 10.1053/j.jrn.2014.07.011. Epub 2014 Sep 17.

36.

Successful Treatment of Hepatitis B Virus-associated Membranous Nephropathy with Entecavir and Immunosuppressive Agents.

Ochi A, Ishimura E, Ichii M, Ohno Y, Nakatani S, Kobayashi I, Shima H, Tsuda A, Shidara K, Mori K, Tamori A, Inaba M.

Nephrology (Carlton). 2014 Sep;19(9):595-6. doi: 10.1111/nep.12292. No abstract available.

PMID:
25156438
37.

Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients.

Ishimura E, Okuno S, Ichii M, Norimine K, Yamakawa T, Shoji S, Nishizawa Y, Inaba M.

J Clin Endocrinol Metab. 2014 Nov;99(11):4315-20. doi: 10.1210/jc.2014-2372. Epub 2014 Aug 5.

PMID:
25093620
38.

Effect of corticosteroid therapy on renal pathology in IgG4-related kidney disease accompanying glomerulonephritis.

Nakatani S, Ishimura E, Sonoda M, Ichii M, Ochi A, Tsuda A, Kobayashi I, Mori K, Osawa M, Inaba M.

Nephrology (Carlton). 2014 Jul;19(7):436-7. doi: 10.1111/nep.12259. No abstract available.

PMID:
24931114
39.

Poor glycemic control and decreased renal function are associated with increased intrarenal RAS activity in Type 2 diabetes mellitus.

Nakatani S, Ishimura E, Naganuma T, Nakatani A, Ichii M, Fukumoto S, Mori K, Emoto M, Nakatani T, Inaba M.

Diabetes Res Clin Pract. 2014 Jul;105(1):40-6. doi: 10.1016/j.diabres.2014.04.019. Epub 2014 Apr 28.

PMID:
24846444
40.

Quantitative analysis of abdominal aortic calcification in CKD patients without dialysis therapy by use of the Agatston score.

Ichii M, Ishimura E, Shima H, Ohno Y, Ochi A, Nakatani S, Tsuda A, Ehara S, Mori K, Fukumoto S, Naganuma T, Takemoto Y, Nakatani T, Inaba M.

Kidney Blood Press Res. 2013;38(2-3):196-204. doi: 10.1159/000355768. Epub 2014 Apr 8.

41.
42.

Significant association of poor glycemic control with increased resistance in efferent arterioles--study of inulin and para-aminohippuric acid clearance in humans.

Tsuda A, Ishimura E, Ohno Y, Ichii M, Nakatani S, Mori K, Fukumoto S, Emoto M, Inaba M.

Diabetes Res Clin Pract. 2014 May;104(2):234-40. doi: 10.1016/j.diabres.2014.01.030. Epub 2014 Feb 11.

PMID:
24598266
43.

Direct inhibitory effects of pioglitazone on hepatic fetuin-A expression.

Ochi A, Mori K, Emoto M, Nakatani S, Morioka T, Motoyama K, Fukumoto S, Imanishi Y, Koyama H, Ishimura E, Inaba M.

PLoS One. 2014 Feb 13;9(2):e88704. doi: 10.1371/journal.pone.0088704. eCollection 2014.

44.

Significant positive relationship between serum magnesium and muscle quality in maintenance hemodialysis patients.

Okazaki H, Ishimura E, Okuno S, Norimine K, Yamakawa K, Yamakawa T, Shoji S, Nishizawa Y, Inaba M.

Magnes Res. 2013 Oct-Dec;26(4):182-7. doi: 10.1684/mrh.2014.0352.

45.

Poor glycemic control is a major factor in the overestimation of glomerular filtration rate in diabetic patients.

Tsuda A, Ishimura E, Ohno Y, Ichii M, Nakatani S, Machida Y, Mori K, Uchida J, Fukumoto S, Emoto M, Nakatani T, Inaba M.

Diabetes Care. 2014;37(3):596-603. doi: 10.2337/dc13-1899. Epub 2013 Oct 15.

PMID:
24130341
46.

Increased active PTH(1-84) fraction as a predictor of poor mortality in male hemodialysis patients.

Inaba M, Okuno S, Imanishi Y, Ishimura E, Yamakawa T, Shoji S.

Osteoporos Int. 2013 Nov;24(11):2863-70. doi: 10.1007/s00198-012-2245-x. Epub 2013 Sep 13.

PMID:
24030285
47.

Hair magnesium, but not serum magnesium, is associated with left ventricular wall thickness in hemodialysis patients.

Ochi A, Ishimura E, Tsujimoto Y, Kakiya R, Tabata T, Mori K, Fukumoto S, Tahara H, Shoji T, Yasuda H, Nishizawa Y, Inaba M.

Circ J. 2013;77(12):3029-36. Epub 2013 Aug 23.

48.

[Angioimmunoblastic T cell lymphoma complicated with endocapillary proliferative glomerulonephritis].

Nanno S, Nakamae H, Kuwamura Y, Ishimura E, Sakabe M, Inaba A, Koh S, Yoshimura T, Nishimoto M, Hayashi Y, Terada Y, Nakane T, Koh H, Nakao Y, Ohsawa M, Hino M.

Rinsho Ketsueki. 2013 Jul;54(7):658-63. Review. Japanese.

PMID:
23912350
49.

Cerebral white matter hyperintensity predicts cardiovascular events in haemodialysis patients.

Naganuma T, Takemoto Y, Shoji T, Shima H, Ishimura E, Okamura M, Nakatani T.

Nephrology (Carlton). 2013 Oct;18(10):676-81. doi: 10.1111/nep.12115.

PMID:
23782310
50.

Nephronectin expression in glomeruli of renal biopsy specimens from various kidney diseases: nephronectin is expressed in the mesangial matrix expansion of diabetic nephropathy.

Nakatani S, Ishimura E, Mori K, Fukumoto S, Yamano S, Wei M, Emoto M, Wanibuchi H, Inaba M.

Nephron Clin Pract. 2012;122(3-4):114-21. doi: 10.1159/000350816. Epub 2013 May 8.

PMID:
23689482

Supplemental Content

Loading ...
Support Center